skip to Main Content


Celebrating Over 80 Years Of Service!

The American Academy of Otolaryngic Allergy (AAOA) represents over 2,700 Board-certified otolaryngologists and health care providers. Otolaryngology, frequently referred to as Ear, Nose, and Throat (ENT), uniquely combines medical and surgical expertise to care for patients with a variety of conditions affecting the ears, nose, and throat, as well as commonly related conditions. AAOA members devote part of their practice to the diagnosis and treatment of allergic disease. The AAOA actively supports its membership through education, research, and advocacy in the care of allergic patients.

"Advance the comprehensive management of allergy and inflammatory disease in Otolaryngology-Head and Neck Surgery through training, education, and advocacy."


United Healthcare Home Immunotherapy Policy Change

United Healthcare has recently announced a policy change. Effective January 1, 2023, UHC will no longer…

Read more

Medicare 2022 Conversion Factor Update

Thanks to lobbying efforts from the House of Medicine, Congress took action this month. The…

Read more

CY 2022 Physician Fee Schedule Proposed Rule Summary

On July 13, the Centers for Medicare & Medicaid Services (CMS) released the Medicare Physician…

Read more

Changes in MACRA

Macra 101 Image

Before the close of 2017, all physicians must take action to avoid the 4 percent cut that will be assessed in 2019 for not participating in the new Quality Payment Program (QPP) authorized by the Medicare Access and CHIP Reauthorization Act (MACRA).  Read More

CMS Announces Changes in MACRA Implementation Timeline. The Centers for Medicare and Medicaid Services (CMS) announced major changes to the implementation of the Medicare Access and CHIP Re-authorization (MACRA).
Read More

Upcoming Dates

06/01/23: Research Grant Cycle
Learn more

06/26/23: Membership Application Deadline to be eligible for AAOA Member rate for the 2023 Basic Course

07/01/23: Scientific Abstract Submission Deadline
Learn more

12/01/23: Research Grant Cycle
Learn more

04/01/24: Fellow Exam Application Deadline
Learn more


2023 AAOA Annual Meeting

Register Now to access over 19 hrs of CME | Continuing Certification through our 2023 Hybrid Annual Meeting. The meeting will take place in Nashville and virtually from September 29 - October 1, 2023. On-Demand post course access will be open until November 14, 2023. Learn More


For information about Resident opportunities, DosedDaily, research grants, and other resources. Learn More


Available Now


IFAR Impact Factor: 2.454

IFAR Featured Content: COVID-19 - Free Access
Endonasal instrumentation and aerosolization risk in the era of COVID‐19: simulation, literature review, and proposed mitigation strategies . Read More

Changes in Managing Practices

Working together with AAOA staff, volunteer leadership and members will enable us to have a positive impact on our members’ practices.

Read More

Live and Online CME

2023 AAOA Basic Course in Allergy & Immunology - Hybrid
September 1 - Access
Learn More and Register

2023 AAOA Annual Meeting - Hybrid
September 29 – October 1, 2023
Embassy Suites by Hilton Nashville Downtown
Learn More and Register

2024 AAOA Advanced Course in Allergy & Immunology - Hybrid
February 8 - 10, 2024
Hyatt Regency Tamaya
Santa Ana Pueblo, New Mexico
(outside Albuquerque)

2024 AAOA Basic Course in Allergy & Immunology - Hybrid
July 25-27, 2024
The Diplomat, Hollywood, Florida
Learn More and Get Hotel Room

2024 AAOA Annual Meeting - Hybrid
November 8-10, 2024
Four Seasons Hotel Las Vegas

USP 797 Online Module
Learn More and Register

AAOA Educational Stacks
Next Availability - November 1, 2023

News and Updates

National Study to Document Changes in Physician Practice Expense

The American Medical Association (AMA) is undertaking a new national study, supported by 173 healthcare organizations,…

Read more

American Elm Shortage

American Elm is dying from Dutch Elm Disease. This may explain the concentrate shortage many practices…

Read more
College Allergy Symptoms Treatment Back to Shcool


AAOA Practice Resource Tool Kit

The American Academy of Otolaryngic Allergy (AAOA) Practice Resource Tool Kit is intended as a guide to help AAOA members integrate allergy into their otolaryngology practice and to continually improve on this integration as new information, regulations, and resources become available.

Read More


AAOA has launched a Partner Resource Center to bring you partner resources that can assist your practice and patient care.

Visit the New Center>


Living With Allergies

How To Treat Allergies At Home

By Dr. Kevin F. Wilson

Ear, Nose, and Throat Specialist

If you suffer from allergies, you’ve got lots of company. Nearly 50 million people nationwide battle allergies of some kind, including pollens, pets, molds, and foods. Allergies can manifest as a variety of problems, including hay fever, asthma, eczema, recurrent ear infections, and chronic hoarseness. Symptoms may include itchy-watery eyes, sneezing, nasal stuffiness and drainage, scratchy throats, and wheezing.

Some allergy sufferers experience symptoms all year. Others may only have problems during certain seasons or with specific exposures. Minimizing exposure to allergens, managing symptoms with medications, and desensitization with allergy shots or drops are all methods that can be useful in con- trolling allergic symptoms.

The best way to avoid allergic symptoms is to avoid the allergen that causes them. Unfortunately, many people don’t know what they’re actually allergic to, and depending on the allergen, it can be impossible to avoid. Still, simple things like wearing a mask when mowing the lawn, changing air filters regularly, and not letting the cat in the bedroom can make a significant difference for some people.

Medications such as nasal steroid sprays or antihistamines can be very helpful to control symptoms. Both over-the-counter and prescription medications are available, each with their advantages and drawbacks.

Immunotherapy, or allergy shots or drops, provides the only treatment method that can offer lasting relief or cure from allergies. This is because immunotherapy shifts the body’s response from an allergic to a non-allergic response. Rather than masking the symptoms of allergy as with medication, it can minimize the symptoms from occurring in the first place.

Allergy shots have been in use for decades. Although effective, shots can be a bit of a hassle. Allergy shots can only be administered in a doctor’s office; physicians also usually monitor patients for about 30 minutes after the shot is administered to make sure there are no adverse effects from the treatment.

Many adults and most children have an understandable aversion to needles. For grown-ups getting the shot, the anticipation every week of a jab in the arm can be emotional torture. Adults who must watch their children endure the pain, albeit quick, of that weekly sting may find it equally as difficult to watch. And the time spent driving to and from the doctor’s office for the weekly shot, then waiting the 30 minutes, can cause significant disruption to the daily routine

That’s why a different approach, known as sublingual immunotherapy (SLIT), has seen a dramatic increase in recent years. Instead of an allergy shot, a patient simply puts a few drops of the solution under their tongue. Patients (or parents) can administer the sublingual drops themselves at home.

Many doctors believe sublingual therapy is safer than allergy shots be- cause the drops under the tongue are absorbed into the system at a slower rate than the traditional allergy shots, thereby reducing the possibility of an adverse reaction.

Sublingual therapy is not new—it has been around since the 1970s and heavily used in Europe for years. In the United States, SLIT has not taken hold as quickly, partially because the treatment is still awaiting approval from the Food and Drug Administration (FDA). Without the go ahead from the FDA, insurance companies will not pay for the therapy. Allergy shots have had approval for years, and most insurance companies reimburse patients for their use.

Although sublingual therapy has not been approved by the FDA, that does not prohibit its prescription by doctors. In addition, numerous studies show the treatment is effective and safe for patient use.

And, it turns out, the cost can be quite comparable, even without insurance coverage.



CMS Announces Changes in MACRA Implementation Timeline. The Centers for Medicare and Medicaid Services (CMS) announced major changes to the implementation of the Medicare Access and CHIP Re-authorization (MACRA). Read More


AAOA brings together a variety of resources to aid you in the management of your practice and your career. Please stop back often or subscribe to our updates to benefit from our offerings.

Back To Top